|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|||
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging Growth Company
|
Page
Number
|
||
Part I.
|
Financial Information:
|
|
Item 1.
|
||
4 |
||
10 |
||
Item 2.
|
||
38 |
||
Item 3.
|
||
53 |
||
Item 4.
|
||
54 |
||
Part II.
|
Other Information:
|
|
Item 2.
|
||
55 |
||
Item 6.
|
||
55 |
||
56 |
Part I |
Financial Information
|
September 30,
2022
|
December 31,
2021
|
|||||||
ASSETS
|
||||||||
Cash and due from banks
|
$
|
|
$
|
|
||||
Federal funds sold and other short-term investments
|
|
|
||||||
Cash and cash equivalents
|
|
|
||||||
Debt securities available for sale, at fair value
|
|
|
||||||
Debt securities held to maturity (fair value 2022
- $
|
|
|
||||||
Federal Home Loan Bank (FHLB) stock
|
|
|
||||||
Loans held for sale, at fair value
|
|
|
||||||
Total loans
|
|
|
||||||
Allowance for loan losses
|
(
|
)
|
(
|
)
|
||||
Net loans
|
|
|
||||||
Premises and equipment – net
|
|
|
||||||
Accrued interest receivable
|
|
|
||||||
Bank-owned life insurance
|
|
|
||||||
Other real estate owned - net
|
|
|
||||||
Net deferred tax asset
|
|
|
||||||
Other assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
Deposits
|
||||||||
Noninterest-bearing
|
$
|
|
$
|
|
||||
Interest-bearing
|
|
|
||||||
Total deposits
|
|
|
||||||
Other borrowed funds
|
|
|
||||||
Accrued expenses and other liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Commitments and contingent liabilities
|
|
|
||||||
Shareholders’ equity
|
||||||||
Common stock,
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total shareholders’ equity
|
|
|
||||||
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
Three Months
Ended
September 30,
2022
|
Three Months
Ended
September 30,
2021
|
Nine Months
Ended
September 30,
2022
|
Nine Months
Ended
September 30,
2021
|
|||||||||||||
Interest income
|
||||||||||||||||
Loans, including fees
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Securities
|
||||||||||||||||
Taxable
|
|
|
|
|
||||||||||||
Tax-exempt
|
|
|
|
|
||||||||||||
FHLB Stock
|
|
|
|
|
||||||||||||
Federal funds sold and other short-term investments
|
|
|
|
|
||||||||||||
Total interest income
|
|
|
|
|
||||||||||||
Interest expense
|
||||||||||||||||
Deposits
|
|
|
|
|
||||||||||||
Other borrowings
|
|
|
|
|
||||||||||||
Long-term debt
|
|
|
|
|
||||||||||||
Total interest expense
|
|
|
|
|
||||||||||||
Net interest income
|
|
|
|
|
||||||||||||
Provision for loan losses
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||
Net interest income after provision for loan losses
|
|
|
|
|
||||||||||||
Noninterest income
|
||||||||||||||||
Service charges and fees
|
|
|
|
|
||||||||||||
Net gains on mortgage loans
|
|
|
|
|
||||||||||||
Trust fees
|
|
|
|
|
||||||||||||
ATM and debit card fees
|
|
|
|
|
||||||||||||
Bank owned life insurance (“BOLI”) income
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total noninterest income
|
|
|
|
|
||||||||||||
Noninterest expense
|
||||||||||||||||
Salaries and benefits
|
|
|
|
|
||||||||||||
Occupancy of premises
|
|
|
|
|
||||||||||||
Furniture and equipment
|
|
|
|
|
||||||||||||
Legal and professional
|
|
|
|
|
||||||||||||
Marketing and promotion
|
|
|
|
|
||||||||||||
Data processing
|
|
|
|
|
||||||||||||
FDIC assessment
|
|
|
|
|
||||||||||||
Interchange and other card expense
|
|
|
|
|
||||||||||||
Bond and D&O Insurance
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total noninterest expenses
|
|
|
|
|
||||||||||||
Income before income tax
|
|
|
|
|
||||||||||||
Income tax expense
|
|
|
|
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Basic earnings per common share
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Diluted earnings per common share
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Cash dividends per common share
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months
Ended
September 30,
2022
|
Three Months
Ended
September 30,
2021
|
Nine Months
Ended
September 30,
2022
|
Nine Months
Ended
September 30,
2021
|
|||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other comprehensive income (loss):
|
||||||||||||||||
Unrealized gains (losses):
|
||||||||||||||||
Net change in unrealized gains (losses) on debt securities available for sale
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net unrealized gain at time of transfer on securities transferred to held-to-maturity
|
||||||||||||||||
Amortization of net unrealized gains on securities transferred to held-to-maturity
|
( |
) | ( |
) | ||||||||||||
Tax effect
|
|
|
|
|
||||||||||||
Net change in unrealized gains (losses) on debt securities available for sale, net of tax
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Less: reclassification adjustments:
|
||||||||||||||||
Reclassification for gains included in net income
|
|
|
|
|
||||||||||||
Tax effect
|
|
|
|
|
||||||||||||
Reclassification for gains included in net income, net of tax
|
|
|
|
|
||||||||||||
Other comprehensive income (loss), net of tax
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Common
Stock
|
Retained Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total
Shareholders’
Equity
|
|||||||||||||
Balance, July 1, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net income for the three months ended September 30, 2021
|
|
|
|
|
||||||||||||
Cash dividends at $
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Repurchase of
|
( |
) | ( |
) | ||||||||||||
Other comprehensive income, net of tax
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Stock compensation expense
|
|
|
|
|
||||||||||||
Balance, September 30, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Balance, July 1, 2022
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Net income for the three months ended September 30, 2022
|
|
|
|
|
||||||||||||
Cash dividends at $
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Repurchase of
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Other comprehensive income, net of tax
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Stock compensation expense
|
|
|
|
|
||||||||||||
Balance, September 30, 2022
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Common
Stock
|
Retained Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total
Shareholders’
Equity
|
|||||||||||||
Balance, January 1, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net income for the nine months ended September 30, 2021
|
|
|
|
|
||||||||||||
Cash dividends at $
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Repurchase of
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Other comprehensive income, net of tax
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Stock compensation expense
|
|
|
|
|
||||||||||||
Balance, September 30, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Balance, January 1, 2022
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Net income for the nine months ended September 30, 2022
|
|
|
|
|
||||||||||||
Cash dividends at $
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Repurchase of
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Other comprehensive income, net of tax
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Stock compensation expense
|
|
|
|
|
||||||||||||
Balance, September 30, 2022
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Nine Months
Ended
September 30,
2022
|
Nine Months
Ended
September 30,
2021
|
|||||||
Cash flows from operating activities
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash from operating activities:
|
||||||||
Depreciation and amortization
|
|
|
||||||
Stock compensation expense
|
|
|
||||||
Provision for loan losses
|
(
|
)
|
(
|
)
|
||||
Origination of loans for sale
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales of loans originated for sale
|
|
|
||||||
Net gains on mortgage loans
|
(
|
)
|
(
|
)
|
||||
Write-down of other real estate
|
|
|
||||||
Net (gain) / loss on sales of other real estate
|
(
|
)
|
|
|||||
Deferred income tax expense
|
|
|
||||||
Earnings in bank-owned life insurance
|
(
|
)
|
(
|
)
|
||||
Change in accrued interest receivable and other assets
|
(
|
)
|
|
|||||
Change in accrued expenses and other liabilities
|
|
(
|
)
|
|||||
Net cash from operating activities
|
|
|
||||||
Cash flows from investing activities
|
||||||||
Loan originations and payments, net
|
(
|
)
|
|
|||||
Purchases of securities available for sale
|
(
|
)
|
(
|
)
|
||||
Purchases of securities held to maturity
|
(
|
)
|
(
|
)
|
||||
Purchase of bank-owned life insurance
|
( |
) | ||||||
Proceeds from:
|
||||||||
Maturities and calls of securities available for sale
|
||||||||
Maturities and calls of securities held to maturity
|
||||||||
Principal paydowns on securities available for sale
|
||||||||
Principal paydowns on securities held to maturity
|
||||||||
Sales of other real estate
|
|
|
||||||
Redemption of FHLB stock
|
||||||||
Payout of bank-owned insurance claim
|
|
|
||||||
Additions to premises and equipment
|
(
|
)
|
(
|
)
|
||||
Net cash from investing activities
|
(
|
)
|
|
|||||
Cash flows from financing activities
|
||||||||
Change in deposits
|
(
|
)
|
|
|||||
Repayments and maturities of other borrowed funds
|
( |
) | ( |
) | ||||
Proceeds from other borrowed funds
|
|
|
||||||
Repurchase of shares for taxes withheld on vested restricted stock
|
(
|
)
|
(
|
)
|
||||
Cash dividends paid
|
(
|
)
|
(
|
)
|
||||
Net cash from financing activities
|
(
|
)
|
|
|||||
Net change in cash and cash equivalents
|
(
|
)
|
|
|||||
Cash and cash equivalents at beginning of period
|
|
|
||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
Nine Months
Ended
September 30,
2022
|
Nine Months
Ended
September 30,
2021
|
|||||||
Supplemental cash flow information
|
||||||||
Interest paid
|
$
|
|
$
|
|
||||
Income taxes paid
|